Company profile: Iveric Bio
1.1 - Company Overview
Company description
- Provider of science-driven biopharmaceutical research and development focused on novel treatment options for retinal diseases with significant unmet medical needs, including age-related macular degeneration, developing therapeutic product candidates for age-related retinal diseases and gene therapy product candidates.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Iveric Bio
Freeline Therapeutics
HQ: United Kingdom
Website
- Description: Provider of transformative adeno-associated virus-vector-mediated systemic gene therapies for systemic debilitating diseases, using a designed AAV vector and capsid with novel promoters and transgenes to deliver a functional copy of a therapeutic gene into human liver cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Freeline Therapeutics company profile →
ViroGates
HQ: Denmark
Website
- Description: Provider of suPARnostic blood test products for better triaging in hospitals, primarily used in emergency departments for risk stratification to improve patient care, reduce healthcare costs, and empower clinical staff.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViroGates company profile →
GenEdit
HQ: United States
Website
- Description: Provider of a proprietary non-viral, non-lipid polymer nanoparticle platform (NanoGalaxy) for safe, efficient delivery of genetic medicine payloads—including nucleic acids, therapeutic proteins, and CRISPR/Cas9—to specific tissues. Offers tissue selectivity, payload flexibility, ability to redose without immune response, and scalable manufacturing with batch-to-batch purity and long-term stability that reduces cold-chain logistics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenEdit company profile →
oncgnostics
HQ: Germany
Website
- Description: Provider of proprietary epigenetic biomarker-based in vitro diagnostic (IVD) tests for cancer screening, therapeutic decisions, and follow-up care, including GynTect and ScreenYu Gyn for detecting methylated DNA regions in cervical cells (ScreenYu Gyn suited for automation and large-scale screening), and saliva-based head and neck tumor diagnostics using DNA methylation markers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full oncgnostics company profile →
Megazyme
HQ: Ireland
Website
- Description: Provider of analytical enzymes, chromogenic substrates, high-purity polysaccharides and colourimetric oligosaccharides; assay kits including Rapid Integrated Total Dietary Fiber and Lactose Assay; and Food Safety Division dehydrated culture media and diagnostic tests for foodborne bacteria, natural toxins, genetic modifications and allergens, serving laboratories in food & beverages, biofuel, animal feed, wine & brewing, dairy and cereals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Megazyme company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Iveric Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Iveric Bio
2.2 - Growth funds investing in similar companies to Iveric Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Iveric Bio
4.2 - Public trading comparable groups for Iveric Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →